The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Decode the Crosstalk Between Bones, Brain, and Fat

Decode the Crosstalk Between Bones, Brain, and Fat

April 1, 2010 • By Kathy Holliman

  • Tweet
  • Email
Print-Friendly Version / Save PDF

However, bone remodeling also requires energy expenditures for both the osteoclasts and the osteoblasts. Thus, an early hypothesis was that bone mass, appetite, and reproduction may be controlled by the same hormones. Only leptin has been identified as the hormone involved in all three. “Leptin is an adipocyte-derived hormone identified for its ability to regulate energy metabolism and reproduction. It appears during evolution much later than energy metabolism and signals in the brain to fulfill its functions,” he said.

You Might Also Like
  • Sensory Nerves May Be Key for Osteoporosis
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • Insight into Crosstalk Between Bone & Immune Systems
Explore This Issue
April 2010
Also By This Author
  • Wisconsin Rheumatologist Visits Rheumatology Training Program in Nepal

Leptin deficiency has many facets, he said, including behavioral abnormalities, small size of the brain, wound-healing defects, immunity defects, and low sympathetic tone. Reflex sympathetic dystrophy is a disease characterized by localized high sympathetic activity and bone loss. This condition has been successfully treated with beta-blockers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Function of Leptin

Researchers had several central questions about the function of leptin. “Where does leptin signal in the brain to regulate bone mass accrual? Where does leptin signal in the brain to regulate energy metabolism? Is there a common molecular basis between these two functions of leptin?” Dr. Karsenty listed.

Through research with several mouse models, Dr. Karsenty and colleagues have found that serotonin is the molecular basis of the central coregulation of bone mass and energy metabolism. It is leptin that regulates these two functions by acting in the brainstem and by inhibiting synthesis and release of serotonin. “Leptin inhibits bone mass accrual, and this function occurs independently of its ability to regulate energy metabolism. This function also occurs only through a central relay,” Dr. Karsenty said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As explained in the research published in Cell, serotonin is produced in cells of the duodenum and in serotonergic neurons of brainstem and does not cross the blood–brain barrier. Because of this mode of production, serotonin is a molecule “with two distinct functional identities depending on its site of synthesis: a hormone when made in the gut and a neurotransmitter when made in the brain.”1

Those roles had been previously known, but serotonin’s role in bone mass had not been identified. Dr. Karsenty and colleagues showed that brain-derived serotonin favors bone mass accrual and appetite, unlike leptin. It is leptin that regulates those functions by inhibiting serotonin synthesis in the neurons of the brainstem.

Mouse Models Instrumental

A series of mouse models were critical to this research, Dr. Karsenty said. For example, one mouse model was unable to synthesize serotonin anywhere in its body. By using this mouse model, the researchers hoped to ascertain the contribution of the brain-derived serotonin on regulation of bone mass accrual. These mice had a low bone mass, a decrease in bone formation, and an increase in bone resorption, thus indicating the role that the brain-derived serotonin has in regulation of bone mass.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: bone remodeling, Genes, leptin, leptin–serotonin pathway, Osteoporosis, ResearchIssue: April 2010

You Might Also Like:
  • Sensory Nerves May Be Key for Osteoporosis
  • Orexin’s Yin/Yang Functions Regulate Bone Remodeling
  • Insight into Crosstalk Between Bone & Immune Systems
  • Researchers Probe the Role of Fat Cells in Inflammation

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.